nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Irinotecan—colon cancer	0.665	1	CbGbCtD
Entacapone—UGT1A9—renal system—colon cancer	0.00264	0.185	CbGeAlD
Entacapone—UGT1A9—digestive system—colon cancer	0.00216	0.152	CbGeAlD
Entacapone—UGT1A9—liver—colon cancer	0.00161	0.113	CbGeAlD
Entacapone—COMT—smooth muscle tissue—colon cancer	0.0015	0.105	CbGeAlD
Entacapone—COMT—renal system—colon cancer	0.00145	0.101	CbGeAlD
Entacapone—COMT—digestive system—colon cancer	0.00119	0.0832	CbGeAlD
Entacapone—COMT—bone marrow—colon cancer	0.00109	0.0767	CbGeAlD
Entacapone—COMT—vagina—colon cancer	0.00105	0.0735	CbGeAlD
Entacapone—COMT—liver—colon cancer	0.000884	0.062	CbGeAlD
Entacapone—COMT—lymph node—colon cancer	0.000678	0.0475	CbGeAlD
Entacapone—Loss of consciousness—Irinotecan—colon cancer	0.000584	0.00182	CcSEcCtD
Entacapone—Myalgia—Vincristine—colon cancer	0.00058	0.00181	CcSEcCtD
Entacapone—Weight increased—Capecitabine—colon cancer	0.00058	0.00181	CcSEcCtD
Entacapone—Cough—Irinotecan—colon cancer	0.000579	0.00181	CcSEcCtD
Entacapone—Weight decreased—Capecitabine—colon cancer	0.000577	0.0018	CcSEcCtD
Entacapone—Hyperglycaemia—Capecitabine—colon cancer	0.000575	0.00179	CcSEcCtD
Entacapone—Hypertension—Irinotecan—colon cancer	0.000573	0.00179	CcSEcCtD
Entacapone—Pneumonia—Capecitabine—colon cancer	0.000572	0.00178	CcSEcCtD
Entacapone—Leukopenia—Fluorouracil—colon cancer	0.000569	0.00177	CcSEcCtD
Entacapone—Depression—Capecitabine—colon cancer	0.000567	0.00177	CcSEcCtD
Entacapone—Acute coronary syndrome—Capecitabine—colon cancer	0.000561	0.00175	CcSEcCtD
Entacapone—Discomfort—Irinotecan—colon cancer	0.000558	0.00174	CcSEcCtD
Entacapone—Neuropathy peripheral—Capecitabine—colon cancer	0.000557	0.00174	CcSEcCtD
Entacapone—Myocardial infarction—Capecitabine—colon cancer	0.000557	0.00174	CcSEcCtD
Entacapone—Oedema—Vincristine—colon cancer	0.000556	0.00173	CcSEcCtD
Entacapone—Conjunctivitis—Capecitabine—colon cancer	0.000553	0.00172	CcSEcCtD
Entacapone—Urinary tract infection—Capecitabine—colon cancer	0.000553	0.00172	CcSEcCtD
Entacapone—Convulsion—Fluorouracil—colon cancer	0.000551	0.00172	CcSEcCtD
Entacapone—Confusional state—Irinotecan—colon cancer	0.000546	0.0017	CcSEcCtD
Entacapone—Nervous system disorder—Vincristine—colon cancer	0.000546	0.0017	CcSEcCtD
Entacapone—Thrombocytopenia—Vincristine—colon cancer	0.000545	0.0017	CcSEcCtD
Entacapone—Haematuria—Capecitabine—colon cancer	0.000542	0.00169	CcSEcCtD
Entacapone—Oedema—Irinotecan—colon cancer	0.000542	0.00169	CcSEcCtD
Entacapone—Myalgia—Fluorouracil—colon cancer	0.000541	0.00169	CcSEcCtD
Entacapone—Chest pain—Fluorouracil—colon cancer	0.000541	0.00169	CcSEcCtD
Entacapone—Hyperhidrosis—Vincristine—colon cancer	0.000538	0.00168	CcSEcCtD
Entacapone—Hepatobiliary disease—Capecitabine—colon cancer	0.000538	0.00168	CcSEcCtD
Entacapone—Epistaxis—Capecitabine—colon cancer	0.000536	0.00167	CcSEcCtD
Entacapone—Discomfort—Fluorouracil—colon cancer	0.000535	0.00167	CcSEcCtD
Entacapone—Shock—Irinotecan—colon cancer	0.000533	0.00166	CcSEcCtD
Entacapone—Nervous system disorder—Irinotecan—colon cancer	0.000531	0.00166	CcSEcCtD
Entacapone—Agranulocytosis—Capecitabine—colon cancer	0.000531	0.00165	CcSEcCtD
Entacapone—Thrombocytopenia—Irinotecan—colon cancer	0.000531	0.00165	CcSEcCtD
Entacapone—Anorexia—Vincristine—colon cancer	0.00053	0.00165	CcSEcCtD
Entacapone—Hyperhidrosis—Irinotecan—colon cancer	0.000524	0.00163	CcSEcCtD
Entacapone—Confusional state—Fluorouracil—colon cancer	0.000523	0.00163	CcSEcCtD
Entacapone—Hypotension—Vincristine—colon cancer	0.00052	0.00162	CcSEcCtD
Entacapone—Bradycardia—Capecitabine—colon cancer	0.00052	0.00162	CcSEcCtD
Entacapone—Oedema—Fluorouracil—colon cancer	0.000519	0.00162	CcSEcCtD
Entacapone—Anorexia—Irinotecan—colon cancer	0.000517	0.00161	CcSEcCtD
Entacapone—Ataxia—Methotrexate—colon cancer	0.000516	0.00161	CcSEcCtD
Entacapone—Haemoglobin—Capecitabine—colon cancer	0.000513	0.0016	CcSEcCtD
Entacapone—Hepatitis—Capecitabine—colon cancer	0.00051	0.00159	CcSEcCtD
Entacapone—Haemorrhage—Capecitabine—colon cancer	0.00051	0.00159	CcSEcCtD
Entacapone—Nervous system disorder—Fluorouracil—colon cancer	0.000509	0.00159	CcSEcCtD
Entacapone—Thrombocytopenia—Fluorouracil—colon cancer	0.000508	0.00158	CcSEcCtD
Entacapone—Hypoaesthesia—Capecitabine—colon cancer	0.000508	0.00158	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000507	0.00158	CcSEcCtD
Entacapone—Pharyngitis—Capecitabine—colon cancer	0.000507	0.00158	CcSEcCtD
Entacapone—Hypotension—Irinotecan—colon cancer	0.000506	0.00158	CcSEcCtD
Entacapone—Urinary tract disorder—Capecitabine—colon cancer	0.000504	0.00157	CcSEcCtD
Entacapone—Insomnia—Vincristine—colon cancer	0.000503	0.00157	CcSEcCtD
Entacapone—Urethral disorder—Capecitabine—colon cancer	0.0005	0.00156	CcSEcCtD
Entacapone—Paraesthesia—Vincristine—colon cancer	0.0005	0.00156	CcSEcCtD
Entacapone—Anorexia—Fluorouracil—colon cancer	0.000495	0.00154	CcSEcCtD
Entacapone—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000495	0.00154	CcSEcCtD
Entacapone—Visual impairment—Capecitabine—colon cancer	0.000492	0.00153	CcSEcCtD
Entacapone—Insomnia—Irinotecan—colon cancer	0.00049	0.00153	CcSEcCtD
Entacapone—Paraesthesia—Irinotecan—colon cancer	0.000487	0.00152	CcSEcCtD
Entacapone—Hypotension—Fluorouracil—colon cancer	0.000485	0.00151	CcSEcCtD
Entacapone—Decreased appetite—Vincristine—colon cancer	0.000484	0.00151	CcSEcCtD
Entacapone—Dyspnoea—Irinotecan—colon cancer	0.000483	0.00151	CcSEcCtD
Entacapone—Erythema multiforme—Capecitabine—colon cancer	0.000483	0.0015	CcSEcCtD
Entacapone—Somnolence—Irinotecan—colon cancer	0.000482	0.0015	CcSEcCtD
Entacapone—Gastrointestinal disorder—Vincristine—colon cancer	0.00048	0.0015	CcSEcCtD
Entacapone—Fatigue—Vincristine—colon cancer	0.00048	0.0015	CcSEcCtD
Entacapone—Eye disorder—Capecitabine—colon cancer	0.000477	0.00149	CcSEcCtD
Entacapone—Dyspepsia—Irinotecan—colon cancer	0.000477	0.00149	CcSEcCtD
Entacapone—Pain—Vincristine—colon cancer	0.000476	0.00148	CcSEcCtD
Entacapone—Constipation—Vincristine—colon cancer	0.000476	0.00148	CcSEcCtD
Entacapone—Cardiac disorder—Capecitabine—colon cancer	0.000474	0.00148	CcSEcCtD
Entacapone—Flushing—Capecitabine—colon cancer	0.000474	0.00148	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000473	0.00147	CcSEcCtD
Entacapone—Decreased appetite—Irinotecan—colon cancer	0.000471	0.00147	CcSEcCtD
Entacapone—Insomnia—Fluorouracil—colon cancer	0.000469	0.00146	CcSEcCtD
Entacapone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000468	0.00146	CcSEcCtD
Entacapone—Fatigue—Irinotecan—colon cancer	0.000467	0.00146	CcSEcCtD
Entacapone—Paraesthesia—Fluorouracil—colon cancer	0.000466	0.00145	CcSEcCtD
Entacapone—Pain—Irinotecan—colon cancer	0.000463	0.00144	CcSEcCtD
Entacapone—Constipation—Irinotecan—colon cancer	0.000463	0.00144	CcSEcCtD
Entacapone—Dyspnoea—Fluorouracil—colon cancer	0.000463	0.00144	CcSEcCtD
Entacapone—Somnolence—Fluorouracil—colon cancer	0.000461	0.00144	CcSEcCtD
Entacapone—Dyspepsia—Fluorouracil—colon cancer	0.000457	0.00142	CcSEcCtD
Entacapone—Gastrointestinal pain—Vincristine—colon cancer	0.000455	0.00142	CcSEcCtD
Entacapone—Decreased appetite—Fluorouracil—colon cancer	0.000451	0.00141	CcSEcCtD
Entacapone—Alopecia—Capecitabine—colon cancer	0.000451	0.00141	CcSEcCtD
Entacapone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000448	0.0014	CcSEcCtD
Entacapone—Mental disorder—Capecitabine—colon cancer	0.000447	0.00139	CcSEcCtD
Entacapone—Feeling abnormal—Irinotecan—colon cancer	0.000447	0.00139	CcSEcCtD
Entacapone—Malnutrition—Capecitabine—colon cancer	0.000444	0.00139	CcSEcCtD
Entacapone—Dysuria—Methotrexate—colon cancer	0.000444	0.00138	CcSEcCtD
Entacapone—Pain—Fluorouracil—colon cancer	0.000444	0.00138	CcSEcCtD
Entacapone—Gastrointestinal pain—Irinotecan—colon cancer	0.000443	0.00138	CcSEcCtD
Entacapone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000441	0.00138	CcSEcCtD
Entacapone—Body temperature increased—Vincristine—colon cancer	0.00044	0.00137	CcSEcCtD
Entacapone—Abdominal pain—Vincristine—colon cancer	0.00044	0.00137	CcSEcCtD
Entacapone—Flatulence—Capecitabine—colon cancer	0.000438	0.00137	CcSEcCtD
Entacapone—Erectile dysfunction—Methotrexate—colon cancer	0.000437	0.00136	CcSEcCtD
Entacapone—Dysgeusia—Capecitabine—colon cancer	0.000435	0.00136	CcSEcCtD
Entacapone—Back pain—Capecitabine—colon cancer	0.00043	0.00134	CcSEcCtD
Entacapone—Body temperature increased—Irinotecan—colon cancer	0.000428	0.00134	CcSEcCtD
Entacapone—Abdominal pain—Irinotecan—colon cancer	0.000428	0.00134	CcSEcCtD
Entacapone—Feeling abnormal—Fluorouracil—colon cancer	0.000428	0.00133	CcSEcCtD
Entacapone—Muscle spasms—Capecitabine—colon cancer	0.000427	0.00133	CcSEcCtD
Entacapone—Pneumonia—Methotrexate—colon cancer	0.000426	0.00133	CcSEcCtD
Entacapone—Depression—Methotrexate—colon cancer	0.000422	0.00132	CcSEcCtD
Entacapone—Vision blurred—Capecitabine—colon cancer	0.000419	0.00131	CcSEcCtD
Entacapone—Tremor—Capecitabine—colon cancer	0.000416	0.0013	CcSEcCtD
Entacapone—Ill-defined disorder—Capecitabine—colon cancer	0.000412	0.00129	CcSEcCtD
Entacapone—Urticaria—Fluorouracil—colon cancer	0.000412	0.00129	CcSEcCtD
Entacapone—Conjunctivitis—Methotrexate—colon cancer	0.000411	0.00128	CcSEcCtD
Entacapone—Body temperature increased—Fluorouracil—colon cancer	0.00041	0.00128	CcSEcCtD
Entacapone—Hypersensitivity—Vincristine—colon cancer	0.00041	0.00128	CcSEcCtD
Entacapone—Sweating—Methotrexate—colon cancer	0.000406	0.00127	CcSEcCtD
Entacapone—Haematuria—Methotrexate—colon cancer	0.000404	0.00126	CcSEcCtD
Entacapone—Malaise—Capecitabine—colon cancer	0.000401	0.00125	CcSEcCtD
Entacapone—Hepatobiliary disease—Methotrexate—colon cancer	0.0004	0.00125	CcSEcCtD
Entacapone—Epistaxis—Methotrexate—colon cancer	0.000399	0.00124	CcSEcCtD
Entacapone—Vertigo—Capecitabine—colon cancer	0.000399	0.00124	CcSEcCtD
Entacapone—Hypersensitivity—Irinotecan—colon cancer	0.000399	0.00124	CcSEcCtD
Entacapone—Asthenia—Vincristine—colon cancer	0.000399	0.00124	CcSEcCtD
Entacapone—Syncope—Capecitabine—colon cancer	0.000398	0.00124	CcSEcCtD
Entacapone—Leukopenia—Capecitabine—colon cancer	0.000398	0.00124	CcSEcCtD
Entacapone—Agranulocytosis—Methotrexate—colon cancer	0.000395	0.00123	CcSEcCtD
Entacapone—Palpitations—Capecitabine—colon cancer	0.000393	0.00122	CcSEcCtD
Entacapone—Loss of consciousness—Capecitabine—colon cancer	0.000391	0.00122	CcSEcCtD
Entacapone—Asthenia—Irinotecan—colon cancer	0.000389	0.00121	CcSEcCtD
Entacapone—Cough—Capecitabine—colon cancer	0.000388	0.00121	CcSEcCtD
Entacapone—Hypertension—Capecitabine—colon cancer	0.000384	0.0012	CcSEcCtD
Entacapone—Hypersensitivity—Fluorouracil—colon cancer	0.000382	0.00119	CcSEcCtD
Entacapone—Haemoglobin—Methotrexate—colon cancer	0.000382	0.00119	CcSEcCtD
Entacapone—Diarrhoea—Vincristine—colon cancer	0.000381	0.00119	CcSEcCtD
Entacapone—Haemorrhage—Methotrexate—colon cancer	0.00038	0.00118	CcSEcCtD
Entacapone—Hepatitis—Methotrexate—colon cancer	0.00038	0.00118	CcSEcCtD
Entacapone—Chest pain—Capecitabine—colon cancer	0.000378	0.00118	CcSEcCtD
Entacapone—Myalgia—Capecitabine—colon cancer	0.000378	0.00118	CcSEcCtD
Entacapone—Pharyngitis—Methotrexate—colon cancer	0.000377	0.00118	CcSEcCtD
Entacapone—Anxiety—Capecitabine—colon cancer	0.000377	0.00118	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000376	0.00117	CcSEcCtD
Entacapone—Urinary tract disorder—Methotrexate—colon cancer	0.000375	0.00117	CcSEcCtD
Entacapone—Discomfort—Capecitabine—colon cancer	0.000374	0.00117	CcSEcCtD
Entacapone—Urethral disorder—Methotrexate—colon cancer	0.000372	0.00116	CcSEcCtD
Entacapone—Diarrhoea—Irinotecan—colon cancer	0.000371	0.00116	CcSEcCtD
Entacapone—Dry mouth—Capecitabine—colon cancer	0.00037	0.00115	CcSEcCtD
Entacapone—Dizziness—Vincristine—colon cancer	0.000368	0.00115	CcSEcCtD
Entacapone—Pruritus—Fluorouracil—colon cancer	0.000367	0.00114	CcSEcCtD
Entacapone—Visual impairment—Methotrexate—colon cancer	0.000366	0.00114	CcSEcCtD
Entacapone—Confusional state—Capecitabine—colon cancer	0.000366	0.00114	CcSEcCtD
Entacapone—Oedema—Capecitabine—colon cancer	0.000363	0.00113	CcSEcCtD
Entacapone—Erythema multiforme—Methotrexate—colon cancer	0.000359	0.00112	CcSEcCtD
Entacapone—Dizziness—Irinotecan—colon cancer	0.000358	0.00112	CcSEcCtD
Entacapone—Shock—Capecitabine—colon cancer	0.000357	0.00111	CcSEcCtD
Entacapone—Nervous system disorder—Capecitabine—colon cancer	0.000356	0.00111	CcSEcCtD
Entacapone—Eye disorder—Methotrexate—colon cancer	0.000355	0.00111	CcSEcCtD
Entacapone—Diarrhoea—Fluorouracil—colon cancer	0.000355	0.00111	CcSEcCtD
Entacapone—Thrombocytopenia—Capecitabine—colon cancer	0.000355	0.00111	CcSEcCtD
Entacapone—Vomiting—Vincristine—colon cancer	0.000354	0.0011	CcSEcCtD
Entacapone—Cardiac disorder—Methotrexate—colon cancer	0.000353	0.0011	CcSEcCtD
Entacapone—Skin disorder—Capecitabine—colon cancer	0.000352	0.0011	CcSEcCtD
Entacapone—Rash—Vincristine—colon cancer	0.000351	0.00109	CcSEcCtD
Entacapone—Hyperhidrosis—Capecitabine—colon cancer	0.000351	0.00109	CcSEcCtD
Entacapone—Dermatitis—Vincristine—colon cancer	0.00035	0.00109	CcSEcCtD
Entacapone—Headache—Vincristine—colon cancer	0.000349	0.00109	CcSEcCtD
Entacapone—Anorexia—Capecitabine—colon cancer	0.000346	0.00108	CcSEcCtD
Entacapone—Vomiting—Irinotecan—colon cancer	0.000345	0.00107	CcSEcCtD
Entacapone—Dizziness—Fluorouracil—colon cancer	0.000343	0.00107	CcSEcCtD
Entacapone—Rash—Irinotecan—colon cancer	0.000342	0.00107	CcSEcCtD
Entacapone—Dermatitis—Irinotecan—colon cancer	0.000341	0.00106	CcSEcCtD
Entacapone—Headache—Irinotecan—colon cancer	0.000339	0.00106	CcSEcCtD
Entacapone—Hypotension—Capecitabine—colon cancer	0.000339	0.00106	CcSEcCtD
Entacapone—Alopecia—Methotrexate—colon cancer	0.000336	0.00105	CcSEcCtD
Entacapone—Mental disorder—Methotrexate—colon cancer	0.000333	0.00104	CcSEcCtD
Entacapone—Malnutrition—Methotrexate—colon cancer	0.000331	0.00103	CcSEcCtD
Entacapone—Nausea—Vincristine—colon cancer	0.00033	0.00103	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00033	0.00103	CcSEcCtD
Entacapone—Vomiting—Fluorouracil—colon cancer	0.00033	0.00103	CcSEcCtD
Entacapone—Insomnia—Capecitabine—colon cancer	0.000328	0.00102	CcSEcCtD
Entacapone—Rash—Fluorouracil—colon cancer	0.000327	0.00102	CcSEcCtD
Entacapone—Dermatitis—Fluorouracil—colon cancer	0.000327	0.00102	CcSEcCtD
Entacapone—Paraesthesia—Capecitabine—colon cancer	0.000326	0.00102	CcSEcCtD
Entacapone—Headache—Fluorouracil—colon cancer	0.000325	0.00101	CcSEcCtD
Entacapone—Dysgeusia—Methotrexate—colon cancer	0.000324	0.00101	CcSEcCtD
Entacapone—Dyspnoea—Capecitabine—colon cancer	0.000323	0.00101	CcSEcCtD
Entacapone—Nausea—Irinotecan—colon cancer	0.000322	0.001	CcSEcCtD
Entacapone—Back pain—Methotrexate—colon cancer	0.00032	0.000998	CcSEcCtD
Entacapone—Dyspepsia—Capecitabine—colon cancer	0.000319	0.000995	CcSEcCtD
Entacapone—Decreased appetite—Capecitabine—colon cancer	0.000315	0.000983	CcSEcCtD
Entacapone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000313	0.000976	CcSEcCtD
Entacapone—Fatigue—Capecitabine—colon cancer	0.000313	0.000975	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—colon cancer	0.000312	0.000972	CcSEcCtD
Entacapone—Pain—Capecitabine—colon cancer	0.00031	0.000967	CcSEcCtD
Entacapone—Constipation—Capecitabine—colon cancer	0.00031	0.000967	CcSEcCtD
Entacapone—Nausea—Fluorouracil—colon cancer	0.000308	0.000961	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—colon cancer	0.000307	0.000957	CcSEcCtD
Entacapone—Feeling abnormal—Capecitabine—colon cancer	0.000299	0.000932	CcSEcCtD
Entacapone—Malaise—Methotrexate—colon cancer	0.000298	0.00093	CcSEcCtD
Entacapone—Vertigo—Methotrexate—colon cancer	0.000297	0.000927	CcSEcCtD
Entacapone—Gastrointestinal pain—Capecitabine—colon cancer	0.000297	0.000925	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—colon cancer	0.000296	0.000923	CcSEcCtD
Entacapone—Cough—Methotrexate—colon cancer	0.000289	0.0009	CcSEcCtD
Entacapone—Urticaria—Capecitabine—colon cancer	0.000288	0.000898	CcSEcCtD
Entacapone—Abdominal pain—Capecitabine—colon cancer	0.000287	0.000894	CcSEcCtD
Entacapone—Body temperature increased—Capecitabine—colon cancer	0.000287	0.000894	CcSEcCtD
Entacapone—Convulsion—Methotrexate—colon cancer	0.000287	0.000894	CcSEcCtD
Entacapone—Chest pain—Methotrexate—colon cancer	0.000282	0.000878	CcSEcCtD
Entacapone—Myalgia—Methotrexate—colon cancer	0.000282	0.000878	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00028	0.000872	CcSEcCtD
Entacapone—Discomfort—Methotrexate—colon cancer	0.000278	0.000867	CcSEcCtD
Entacapone—Confusional state—Methotrexate—colon cancer	0.000272	0.000849	CcSEcCtD
Entacapone—Hypersensitivity—Capecitabine—colon cancer	0.000267	0.000833	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—colon cancer	0.000265	0.000825	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—colon cancer	0.000264	0.000824	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—colon cancer	0.000262	0.000818	CcSEcCtD
Entacapone—Hyperhidrosis—Methotrexate—colon cancer	0.000261	0.000814	CcSEcCtD
Entacapone—Asthenia—Capecitabine—colon cancer	0.00026	0.000811	CcSEcCtD
Entacapone—Anorexia—Methotrexate—colon cancer	0.000257	0.000802	CcSEcCtD
Entacapone—Pruritus—Capecitabine—colon cancer	0.000257	0.0008	CcSEcCtD
Entacapone—Hypotension—Methotrexate—colon cancer	0.000252	0.000787	CcSEcCtD
Entacapone—Diarrhoea—Capecitabine—colon cancer	0.000248	0.000774	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000246	0.000767	CcSEcCtD
Entacapone—Insomnia—Methotrexate—colon cancer	0.000244	0.000761	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—colon cancer	0.000242	0.000756	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—colon cancer	0.000241	0.00075	CcSEcCtD
Entacapone—Somnolence—Methotrexate—colon cancer	0.00024	0.000748	CcSEcCtD
Entacapone—Dizziness—Capecitabine—colon cancer	0.00024	0.000748	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—colon cancer	0.000238	0.000741	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—colon cancer	0.000235	0.000732	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000233	0.000727	CcSEcCtD
Entacapone—Fatigue—Methotrexate—colon cancer	0.000233	0.000726	CcSEcCtD
Entacapone—Pain—Methotrexate—colon cancer	0.000231	0.00072	CcSEcCtD
Entacapone—Vomiting—Capecitabine—colon cancer	0.000231	0.000719	CcSEcCtD
Entacapone—Rash—Capecitabine—colon cancer	0.000229	0.000713	CcSEcCtD
Entacapone—Dermatitis—Capecitabine—colon cancer	0.000228	0.000712	CcSEcCtD
Entacapone—Headache—Capecitabine—colon cancer	0.000227	0.000708	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—colon cancer	0.000222	0.000694	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—colon cancer	0.000221	0.000688	CcSEcCtD
Entacapone—Nausea—Capecitabine—colon cancer	0.000215	0.000672	CcSEcCtD
Entacapone—Urticaria—Methotrexate—colon cancer	0.000214	0.000669	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—colon cancer	0.000213	0.000665	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—colon cancer	0.000213	0.000665	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—colon cancer	0.000199	0.00062	CcSEcCtD
Entacapone—Asthenia—Methotrexate—colon cancer	0.000194	0.000604	CcSEcCtD
Entacapone—Pruritus—Methotrexate—colon cancer	0.000191	0.000595	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—colon cancer	0.000185	0.000576	CcSEcCtD
Entacapone—Dizziness—Methotrexate—colon cancer	0.000179	0.000557	CcSEcCtD
Entacapone—Vomiting—Methotrexate—colon cancer	0.000172	0.000535	CcSEcCtD
Entacapone—Rash—Methotrexate—colon cancer	0.00017	0.000531	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—colon cancer	0.00017	0.00053	CcSEcCtD
Entacapone—Headache—Methotrexate—colon cancer	0.000169	0.000527	CcSEcCtD
Entacapone—Nausea—Methotrexate—colon cancer	0.00016	0.0005	CcSEcCtD
